SAEN — Genenta Science S.p.A.

—
Nasdaq · Health Care · Biotechnology · CIK 1838716 ·
Last close
$0.58
Market Cap
$27.82M
52W High
$2.58
52W Low
$0.55
ADV30
114,649
Next earnings
—
Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Dec 2025 — — — — 31,889,310 5,527,672 10,048,670

Balance + Analyst (yfinance extras)

Retained Earnings
$-62,585,347
Inventory
—
Receivables
$1,285,630
ST Investments
$22,621,518
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -6,603,740 -6,529,827 31,889,310 10,048,670 21,840,640 -6,867,959
Dec 2024 0 -9,764,310 -8,912,495 14,823,993 2,328,287 12,495,706 -6,240,174
Dec 2023 0 -11,732,942 -11,645,455 22,347,145 1,914,888 20,432,257 -11,205,023
Dec 2022 0 -11,043,992 -8,477,763 33,437,860 2,299,694 31,138,166 -7,418,236

Peers — same industry

TickerNameMarket CapLastDaily %
PTHS Pelthos Therapeutics Inc. $26.89M $6.84 —
INMB Inmune Bio, Inc. $29.72M $0.96 —
LONA LeonaBio, Inc. $26.00M $2.76 —
EXOZ EXOZYMES INC. $30.80M $3.31 —
EVAX Evaxion A/S $25.08M $2.78 —

Recent Insider Activity

No insider activity indexed for this ticker.